🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple sclerosis is the most common inflammatory disease of the central n...
Status
Terminated
Location
Johns Hopkins University
Start Date
2021-10-01
Trial ID
NCT04767698
Treatments Being Tested
This study is an open-label, randomized, 2 parallel group, single dose stud...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-12-26
Trial ID
NCT01516450
Treatments Being Tested
GlaxoSmithKline (GSK) have submitted a Biologic License Application (BLA) f...
Status
No Longer Available
Location
GSK Investigational Site
Start Date
TBD
Trial ID
NCT03125486
Treatments Being Tested
The purpose of this study is to measure the amount of belimumab in the bloo...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01583530
This will be a randomized, parallel-group, open-label, single-dose study of...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-10-14
Trial ID
NCT01894360
Treatments Being Tested
This is an open-label, randomized, parallel group, single dose study in hea...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-10-28
Trial ID
NCT04136145
Treatments Being Tested
The purpose of this study is to assess whether co-administration of belimum...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-03-01
Trial ID
NCT03312907
The purpose of this study is to evaluate the pharmacokinetics (PK), safety,...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2019-11-28
Trial ID
NCT04179032
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11-16
Trial ID
NCT01484496
Treatments Being Tested
The purpose of this study is to test the safety and tolerability of repeate...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2008-10
Trial ID
NCT00732940
Treatments Being Tested